An evaluation point of care COVID-19 antibody testing in the ED [COVID-19]
Research type
Research Study
Full title
A service evaluation study of commercial point of care Covid-19 antibody testing (CAT) in emergency department (ED) staff. A pilot study.
IRAS ID
284966
Contact name
Chetan Trivedy
Contact email
Sponsor organisation
Brighton and Sussex University Hospital
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 3 months, 1 days
Research summary
The aims of this study are to evaluate the accuracy of a single commercially available COVID- 19 antibody kit (2019-nCoV IgG/IgM Rapid Test Cassette, One-Step) from Home Health3. The test strips will be used to evaluate the immune response in emergency department staff (doctors and nurses) who were symptomatic for Covid-19. The study will recruit ED staff who are at least three-week post symptoms and who have been swab tested. The findings of the swab will be correlated with the antibody tests. A secondary aim is to compare any variability of results between different commercial providers, and we are in the process of acquiring a comparable kit from another supplier. In the instance that this is available both cassettes will be used simultaneously for each subject.
REC name
North West - Greater Manchester South Research Ethics Committee
REC reference
20/NW/0289
Date of REC Opinion
24 Jul 2020
REC opinion
Further Information Favourable Opinion